Carac

Carac is a brand name of fluorouracil topical, approved by the FDA in the following formulation(s):

CARAC (fluorouracil - cream; topical)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: October 27, 2000
  
  Strength(s): 0.5% ^[RLD]

Has a generic version of Carac been approved?

No. There is currently no therapeutically equivalent version of Carac available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Carac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Fluorouracil-containing formulation
  Patent 6,670,335
  Issued: December 30, 2003
  Inventor(s): B. Sandhya; Singh & Subhash J.; Saxena
  Assignee(s): A. P. Pharma, Inc.
  Oil-in-water emulsion formulations contain both free fluorouracil and fluorouracil impregnated in porous microparticles. The formulations are suitable for topical administration, and are useful for the treatment of solar keratoses, actinic keratoses, and superficial basal cell carcinomas.
  
  Patent expiration dates:
  
  
  • June 2, 2021
    
    ✓ 
    Patent use: TREATMENT OF ACTINIC KERATOSIS
    ✓ 
    Drug product
  
  

See also...

• Carac Cream Consumer Information (Wolters Kluwer)
• Carac Consumer Information (Cerner Multum)
• Carac Topical Advanced Consumer Information (Micromedex)
• Fluorouracil Cream Consumer Information (Wolters Kluwer)
• Fluorouracil topical Consumer Information (Cerner Multum)
• Fluorouracil Topical Advanced Consumer Information (Micromedex)
• Fluorouracil topical AHFS DI Monographs (ASHP)